FDA Advisors Recommend Approval Of Taxol for Node-Positive Breast Cancer
In Brief: Justice Department Files Civil Suit To recover $25 Billion From Tobacco
ODAC Actions: Large Subset analysis Of CALGB Study Was Basis for BMS Taxol Application
UFT – Leucovorin Combo Not A Breakthrough, But could Merit Approval, Committee Says
Roferon A Application Marred By Mission Data, Protocol, Compliance
Underpowered Study Of Evacet Dashes Approval Hopes
NCI Programs: Institute Funds 24 DNA Microarray Centers
Trending Stories
- As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded - Pancreatic cancer breakthrough came from smart scientists making smart bets—not from politicization of science
- The story of daraxonrasib is the ultimate hero’s journey
A narrative curve with twists, turns, intrigue, drama—and a blow to a mighty foe - Proposed OMB rule aims at the heart of the U.S. research enterprise—and scientists are fighting back
“The question isn’t whether politics will influence research. Under this proposal, that’s the point. That’s their goal.” - At Senate hearing, Brown’s El-Deiry and other witnesses say they were targeted for arguing that mRNA vaccine may be linked to cancer
- Pancreatic cancer finally starts to budge as daraxonrasib doubles overall survival
